Share Your Experience to Drive COVID-19 Research
Participating is Easy
- Create an account here.
- Share your experiences.
- Receive updates on COVID-19 Study insights and progress.
What You Can Expect From Us
- Each questionnaire takes about 5 minutes to complete.
- Participation is anonymous and your data is privacy protected.
- Only one copy of your data exists, and never leaves the platform.
- You can delete your profile and data at any time.
- Study progress and discoveries will be shared with you.
A Look at the Behavior, Physical, and Mental Wellness Effects of COVID-19
The COVID-19 Study kicked off in March 2020. Since then, LunaDNA members from across the country and beyond have submitted over 340,000 responses revealing some remarkable early insights to help better understand the pandemic.
Events in 2020 have impacted all our lives and lay the groundwork for lessons we can learn. Sharing your physical and mental wellness during this unique time can surface insights to improve our current state and better prepare us for the future. Five minutes of your time will support invaluable research.
Want to Build a COVID-19 Study Community?
Leverage the existing study framework or create your own research questions. We can get you started quickly.
We’ve partnered with trusted organizations to support health research.
© 2020 LunaPBC. All rights reserved.
About Us
LunaDNA was created by the Public Benefit Corporation, LunaPBC™, a team of passionate genomics and technology veterans.
2020
Most Innovative Companies
Fast Company
2019
Technology Pioneers
World Economic Forum
The COVID-19 Study preserves your privacy, is simple to join, and is free of charge.
The COVID-19 Study gives people and communities the tools to gather their experiences during this unique time, recognizing that each person, community, and geography is impacted differently and may experience different long-term effects.
“
”
You can present yourself as a community and find researchers who are willing and eager to work with you. [This program] allows patient information to be brought together to be truly meaningful for research.
— Durhane Wong-Rieger, President and CEO
Canadian Organization for Rare Disorders (CORD)
